SG11202002250VA - Pentosan polysulfate and method for producing pentosan polysulfate - Google Patents

Pentosan polysulfate and method for producing pentosan polysulfate

Info

Publication number
SG11202002250VA
SG11202002250VA SG11202002250VA SG11202002250VA SG11202002250VA SG 11202002250V A SG11202002250V A SG 11202002250VA SG 11202002250V A SG11202002250V A SG 11202002250VA SG 11202002250V A SG11202002250V A SG 11202002250VA SG 11202002250V A SG11202002250V A SG 11202002250VA
Authority
SG
Singapore
Prior art keywords
pentosan polysulfate
producing
polysulfate
pentosan
producing pentosan
Prior art date
Application number
SG11202002250VA
Inventor
Kotaro Ishikawa
Takuro Kashiwamura
Takuya Kato
Toru Koga
Suguru Ishikawa
Original Assignee
Oji Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oji Holdings Corp filed Critical Oji Holdings Corp
Publication of SG11202002250VA publication Critical patent/SG11202002250VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0057—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Sustainable Development (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202002250VA 2017-09-12 2018-09-11 Pentosan polysulfate and method for producing pentosan polysulfate SG11202002250VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017175133 2017-09-12
PCT/JP2018/033535 WO2019054344A1 (en) 2017-09-12 2018-09-11 Pentosan polysulfate and method for producing pentosan polysulfate

Publications (1)

Publication Number Publication Date
SG11202002250VA true SG11202002250VA (en) 2020-04-29

Family

ID=65722707

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202002250VA SG11202002250VA (en) 2017-09-12 2018-09-11 Pentosan polysulfate and method for producing pentosan polysulfate

Country Status (12)

Country Link
US (1) US11390693B2 (en)
EP (1) EP3683242A4 (en)
JP (2) JP7167039B2 (en)
KR (1) KR20200051688A (en)
CN (1) CN111065655B (en)
AU (1) AU2018333249B2 (en)
BR (1) BR112020004787A2 (en)
CA (1) CA3075485A1 (en)
MX (1) MX2020002726A (en)
PH (1) PH12020500458A1 (en)
SG (1) SG11202002250VA (en)
WO (1) WO2019054344A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102533822B1 (en) * 2017-12-20 2023-05-17 오지 홀딩스 가부시키가이샤 Polypentoic acid and medicaments containing polypentoic acid
JP6935960B2 (en) * 2018-08-20 2021-09-15 株式会社レクメド New pentosan polysulfate sodium preparation

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4843100B1 (en) 1969-09-05 1973-12-17
US4168742A (en) 1978-03-27 1979-09-25 Hudson Products Corporation Tube bundle
JPS55127904A (en) 1979-03-24 1980-10-03 Kubota Ltd Power tiller
FR2538404B1 (en) 1982-12-28 1985-08-23 Anic Spa
FR2543145B1 (en) * 1983-03-24 1986-10-17 Sanofi Sa NOVEL XYLAN SULPHATES, THEIR PREPARATION PROCESS AND THEIR ANTI-THROMBOTIC AND HYPOLIPEMIC ACTIVITY
JPS60112708A (en) 1983-11-24 1985-06-19 Maruho Kk Humectant for skin
FR2572731B1 (en) * 1984-11-07 1987-03-06 Sanofi Sa NOVEL LOW MOLECULAR WEIGHT XYLAN SULPHATES, PROCESS FOR THEIR PREPARATION AND ORAL ANTITHROMBOTIC AND HYDROPHOLIC ACTIVITY
JPS61130301A (en) * 1984-11-30 1986-06-18 Tokyo Univ Xylofuranan sulfate having anticoagulant activity and its production
JPS61130302A (en) * 1984-11-30 1986-06-18 Tokyo Univ Ribofuranan sulfate having anticoagulant activity and its production
US5672334A (en) 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
FR2645745B1 (en) 1989-04-12 1991-09-27 Anben Ste Civile THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF SNORING
DE3917982A1 (en) 1989-06-02 1990-12-06 Behringwerke Ag USE OF XYLANPOLYHYDROGENSULFATES FOR THE THERAPY OF CELL PROBLEMATION-RELATED DISEASES
FR2648463B1 (en) * 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer SULPHATE POLYSACCHARIDES, ANTICOAGULATING AGENT AND ANTI-COMPLEMENTARY AGENT OBTAINED FROM BROWN ALGAE FUCANES AND PROCESS FOR OBTAINING SAME
CA2081340A1 (en) 1990-04-26 1991-10-27 R. Martin Emanuele Composition and method for topical treatment of damaged or diseased tissue
US20010005720A1 (en) 1995-06-07 2001-06-28 U.S.A. As Represented By The Secretary Department Of Health And Human Services Method of treating chronic progressive vascular scarring diseases
DE19632840A1 (en) 1996-08-14 1998-02-19 Landsberger Albert Composition containing vitamin A
JPH10195107A (en) 1997-01-10 1998-07-28 Shiseido Co Ltd Sulfated oligohyaluronic acid
JP4336905B2 (en) 1997-12-19 2009-09-30 マルホ株式会社 Skin moisturizing emulsion lotion containing sulfated polysaccharide
US6593310B1 (en) 2000-11-21 2003-07-15 Arthropharm Pty. Ltd. Treatment of osteoporosis
DE10141106A1 (en) 2001-08-22 2003-03-13 Aventis Pharma Gmbh Use of heparinoid derivatives for the treatment and diagnosis of heparinoid-treatable diseases
JP4073661B2 (en) 2001-12-20 2008-04-09 王子製紙株式会社 Method for producing acidic xylooligosaccharide composition
JP3772749B2 (en) 2002-01-25 2006-05-10 王子製紙株式会社 Melanin production inhibitor
JP2003221339A (en) 2002-01-29 2003-08-05 Oji Paper Co Ltd Anti-inflammatory agent
ITMI20031618A1 (en) 2003-08-06 2005-02-07 Inalco Spa POLYSACCHARIDE DERIVATIVES EQUIPPED WITH HIGH ACTIVITY
PT1748781E (en) 2004-05-27 2013-01-22 Baxter Int Methods for treating bleeding disorders using sulfated polysaccharides
US7902158B2 (en) 2004-08-05 2011-03-08 Ivax Drug Research Ltd. Polysulfated glycosides and salts thereof
JP2006225321A (en) * 2005-02-17 2006-08-31 Tosoh Corp Thin film composed of 1,3,5-triazine derivative and method for producing the same thin film
US20060194759A1 (en) 2005-02-25 2006-08-31 Eidelson Stewart G Topical compositions and methods for treating pain and inflammation
WO2007014155A2 (en) 2005-07-22 2007-02-01 Trf Pharma, Inc. Method for treating sickle cell disease and sickle cell disease sequelae
CA2648578A1 (en) 2006-04-03 2007-11-01 Nutramax Laboratories, Inc. Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them
GB0610350D0 (en) 2006-05-25 2006-07-05 Univ Liverpool prevention and/or treatment of neuodegenerative disorders
JPWO2008066193A1 (en) 2006-11-27 2010-03-11 チッソ株式会社 Cosmetic composition
US20100105889A1 (en) 2007-03-06 2010-04-29 Pandurang Balwant Deshpande Process for the preparation of pentosan polysulfate or salts thereof
FI121811B (en) 2007-06-01 2011-04-29 Upm Kymmene Corp New dispersions and processes for their preparation
HUP0900072A2 (en) 2009-02-06 2010-09-28 Egis Gyogyszergyar Nyilvanosan Transdermal pharmaceutical compositions
WO2009087581A1 (en) 2008-01-04 2009-07-16 Alembic Limited An improved process for the preparation of pentosan polysulfate or salts thereof
JP2009196915A (en) 2008-02-20 2009-09-03 Ezaki Glico Co Ltd Composition for cosmetic
AU2008100730B4 (en) 2008-07-04 2008-10-02 Parnell Technologies Pty Ltd Sulfated polysaccharide compound for clinical use and the preparation thereof
FR2935386B1 (en) * 2008-08-26 2010-09-10 Sanofi Aventis NOVEL POLYSACCHARIDES WITH ANTITHROMBOTIC ACTIVITY COMPRISING A COVALENT LIAISON WITH AN AMINO CHAIN
CN102300870B (en) 2009-02-02 2014-12-03 大塚化学株式会社 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
CN102061323B (en) 2010-11-10 2013-09-25 山东龙力生物科技股份有限公司 Comprehensive utilization process of wood cellulose
WO2012101544A1 (en) 2011-01-29 2012-08-02 Alembic Pharmaceuticals Limited An improved process for the preparation of pentosan polysulfate or salts thereof
WO2012114349A1 (en) 2011-02-23 2012-08-30 Cadila Healthcare Limited An improved process for the preparation of pentosan polysulfate sodium
CN102766225B (en) 2011-05-06 2015-08-05 上海医药工业研究院 A kind of piperylene gathers the preparation method of sodium sulfate and a kind of oligomeric xylose
WO2013186857A1 (en) 2012-06-12 2013-12-19 株式会社リボミック Aptamer to fgf2 and use thereof
ITMI20130112A1 (en) * 2013-01-24 2014-07-25 Chemi Spa QUALIFICATION METHOD OF PENTOSAN POLYPHOSPHATE PREPARATIONS, ITS RAW MATERIALS AND PRODUCTION PROCESSES
JO3529B1 (en) 2013-02-08 2020-07-05 Amgen Res Munich Gmbh Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
JP6132302B2 (en) 2013-05-28 2017-05-24 リーディアント・バイオサイエンシーズ・ソシエタ・アノニマＬｅａｄｉａｎｔ Ｂｉｏｓｃｉｅｎｃｅｓ Ｓ．Ａ． Derivatives of partially desulfated glycosaminoglycans as heparanase inhibitors with anti-angiogenic activity and no anticoagulant effect
CN103320548A (en) 2013-06-24 2013-09-25 稼禾生物股份有限公司 Method for preparing xylooligosaccharide and cellulose by using crop straws
JP6403317B2 (en) 2013-07-19 2018-10-10 学校法人慶應義塾 Antitumor agent
CA2984356A1 (en) 2015-05-20 2016-11-24 Chemi Spa Process for the preparation of polysaccharides
AU2016267264A1 (en) 2015-05-27 2017-12-07 Vanguard Therapeutics, Inc. Pentosan polysulfate sodium for the treatment of sickle cell disease
CN106832020A (en) 2015-12-04 2017-06-13 长春工业大学 A kind of preparation technology of maize straw Pentosan sulphate
CN105907896B (en) 2016-05-16 2019-11-12 中国科学院广州能源研究所 A method of utilizing lignocellulose raw material coproduction high concentration xylose and xylo-oligosaccharide
JP6225321B1 (en) 2016-08-31 2017-11-08 王子ホールディングス株式会社 Method for producing polysulfate pentosan
WO2018043667A1 (en) 2016-08-31 2018-03-08 王子ホールディングス株式会社 Production method for acidic xylooligosaccharide, and acidic xylooligosaccharide
JP6281659B1 (en) 2017-02-28 2018-02-21 王子ホールディングス株式会社 Polysulfate pentosan, pharmaceutical composition and anticoagulant
MX2019014445A (en) * 2017-05-31 2020-02-10 Oji Holdings Corp Moisturizing topical preparation.
KR102533822B1 (en) * 2017-12-20 2023-05-17 오지 홀딩스 가부시키가이샤 Polypentoic acid and medicaments containing polypentoic acid

Also Published As

Publication number Publication date
CN111065655A (en) 2020-04-24
CN111065655B (en) 2022-06-14
PH12020500458A1 (en) 2020-12-07
JP2022180509A (en) 2022-12-06
AU2018333249B2 (en) 2023-03-02
KR20200051688A (en) 2020-05-13
BR112020004787A2 (en) 2020-09-24
US11390693B2 (en) 2022-07-19
US20200270372A1 (en) 2020-08-27
CA3075485A1 (en) 2019-03-21
EP3683242A1 (en) 2020-07-22
JP7167039B2 (en) 2022-11-08
WO2019054344A1 (en) 2019-03-21
EP3683242A4 (en) 2021-11-03
MX2020002726A (en) 2020-07-20
AU2018333249A1 (en) 2020-04-02
JPWO2019054344A1 (en) 2020-10-15

Similar Documents

Publication Publication Date Title
PL3140097T3 (en) Multilayer body and method for producing same
EP3329943A4 (en) Method for producing medical device and medical device
PL3628398T3 (en) Method for preparing an encapsulated product and encapsulated product
SG11202001822WA (en) Production method for pentosan polysulfate
EP3219671A4 (en) Aerogel and manufacturing method thereof
ZA201705927B (en) Wrapped object, mandrel therefor and method
PT3204207T (en) Method for the further processing of a prefabricated product, and associated prefabricated product
PT2948481T (en) Method for the qualification of preparations of pentosan polysulfate, raw materials and production processes thereof
EP3395366C0 (en) Drug design method, obtained drug and application thereof
HK1256028A1 (en) Medicament container and method for producing same
GB201501603D0 (en) Method and product
EP3154360C0 (en) Dairy products and methods for producing them
SG11201810789WA (en) Case and method for producing case
TWI562884B (en) Manufacturing method and manufacturing system
IL246831B (en) Method for producing 1-indanoles and 1-indanamines
IL246363B (en) Getter structure and method for forming such structure
SG11201701354VA (en) Oligosaccharide preparation and method for producing the same
SG11202002250VA (en) Pentosan polysulfate and method for producing pentosan polysulfate
GB201503420D0 (en) Composite product and method
HK1257184A1 (en) Film-wound body, and method for producing film-wound body
PL3197654T3 (en) Preforms and method for producing preforms
SG11201701075UA (en) Method for producing dip-formed article, and dip-formed article
HK1251917A1 (en) Wired pipe and method for making
EP3189265A4 (en) Pipe-junction gate system and method
HUE055225T2 (en) Package and method for producing said package